Immunotherapy Treatment Xilonix for CRC

Please feel free to read, share your thoughts, your stories and connect with others!
User avatar
DH2Sleen
Posts: 81
Joined: Thu Jan 29, 2015 10:10 am

Re: Immunotherapy Treatment Xilonix for CRC

Postby DH2Sleen » Thu Sep 29, 2016 10:20 am

aja1121 wrote:CT scan is STABLE. Moving forward with Xilonix trial for another 8 weeks :)

I think it is awesome that this trial has him stable. Maybe this trial will clear up the confusion from the earlier trials. Good luck!
DW, Sleen dx 9/2013 @47yo: IIIc T4b N2b MX
9/2013 colectomy
10/2013 - 3/2014 FOLFOX
4/2014 - 6/2014 Rad to bladder
12/2014 +'ve for lung mets, MX becomes M1
3/2015 enter TIL trial @ NIH
7/1/15 Receive 148E9 cells to target K-ras G12D mutation
8/11/15 Reduction=18%, no new tumors
9/15/15 25%
10/20/15 27%; PET -> one hot met
11/24/15 30% all mets shrinking
1/26/16 46% but one suspicious met
3/24/16 46% but one growing
4/7/16 Lung lobectomy NED for the first time
3/3/20 Still NED "cured"

NateA
Posts: 115
Joined: Sun Aug 02, 2015 7:41 pm
Facebook Username: Nathan Drew Allen

Re: Immunotherapy Treatment Xilonix for CRC

Postby NateA » Fri Sep 30, 2016 10:51 am

We like stable :)
7/15 dx CC stage 4 with lots of liver mets CEA 208
KRAS Mutant G12V, MSS.
9/23 from folfoxiri to folfox and Xeloda. CEA 25
11/11/15 all liver markers in the zone, CEA 4.0, moving to Avastin/xeloda for now..tumors shrinking
01/13/16 Avastin/xeloda CEA 3.5
03/11/16 clean PET CEA 4.4

aja1121
Posts: 214
Joined: Sat Jun 28, 2014 5:12 pm

Re: Immunotherapy Treatment Xilonix for CRC

Postby aja1121 » Tue Nov 22, 2016 11:52 pm

My husband is off the Xilonix trial. Scans yesterday showed 4 sub-centimeter lung nodules. Looking back, these were barely visible on September scan, so things were probably just slowly growing rather than stable. He has not had Avastin yet, so starting Xeloda/Avastin next week.
05/23/14 DH dx Stage 3B rectal ca (age 41)
6/2014 chemorad | 10/2014 LAR, all nodes clean
FOLFOX x 10 | VATS/lung met | ileo reversal
09/15 local recurrence
10/15 colostomy
11/15 FOLFIRI x 4, major growth
02/16 tumor debulked
Stable ten months on Xeloda/Avastin
Growth on clinical trials NCT02024607 (BBI608 + FOLFIRI), NCT02817633 (anti-PD-1 + anti-TIM-3), NCT03175224 (c-Met inhibitor)
09/27/2018 started hospice
02/07/19 died


Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”



Who is online

Users browsing this forum: Google [Bot] and 144 guests